
Pfizer Inc.
PFE 25.06 (-2.67%) 0.67
Health Care
Pharmaceuticals
Quality Checklist 3/8
Debt/Equity < 1
Current Ratio > 1
Net Margin > 10%
5Y Shares Out Change < 0%
ROIC > 10%
Quick Ratio > 1
Past Net Income CAGR > 0%
Est. EPS Growth > 5%
0.0%of Portfolio
My holdings
Day change:
Total change:
Shares:Cost basis:
Market cap: $142.48(B)
EV: $189.73(B)
Total Equity: $93.10(B)
Earnings date: Feb-03-2026
P/E: 14.49
Forward P/E: 7.98
P/FCF: 13.77
P/S: 2.27
P/B: 1.54
EPS: $1.7
EPS (fwd): $3.1
FCF/share: $1.8
Revenue/share: $11.1
Book value/share: $16.3
ROIC: 6.3%
ROA: 4.6%
ROE: 10.6%
Debt/Equity: 0.67
Current Ratio: 1.30
Gross margin: 74.8%
Operating margin: 24.6%
Net margin: 15.7%
Dividend/share: $1.7
Div. yield: 6.78%
Growth Estimates
Revenue
CAGR: -3.5%FY+1$62.65(B)
FY+2(-1.0%)$62.03(B)
FY+3(-3.0%)$60.14(B)
FY+4(-5.0%)$57.15(B)
FY+5(-4.9%)$54.32(B)
Net Income
CAGR: -6.2%FY+1$17.95(B)
FY+2(-0.6%)$17.84(B)
FY+3(-2.7%)$17.36(B)
FY+4(-9.8%)$15.65(B)
FY+5(-11.3%)$13.89(B)
EPS
CAGR: -6.4%FY+1$3.14
FY+2(-0.3%)$3.13
FY+3(-2.9%)$3.04
FY+4(-10.5%)$2.72
FY+5(-11.4%)$2.41
FCF per share
CAGR: -0.4%FY+1$2.93
FY+2(+16.9%)$3.42
FY+3(-3.7%)$3.29
FY+4(-6.6%)$3.08
FY+5(-6.3%)$2.88
